Who Owns Arcutis Biotherapeutics, Inc. (ARQT)?Hedge Fund & Institutional Holders
Institutional Holders
50
as of Q4 2025
Total Institutional Value
$3.4743428675524024e+250T
% of Float Held
Infinity%
QoQ Change in Holders
+14 / -0
Price History
ARQT — Biggest New Institutional Buyers This Quarter
| Fund | Action | Shares Added | Value Added |
|---|---|---|---|
| JENNISON ASSOCIATES LLC | New Position | +6.8M | +$196.3M |
| PRICE T ROWE ASSOCIATES INC /MD/ | Increased | +1.1M | +$31.3M |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | New Position | +900K | +$26.0M |
| FEDERATED HERMES, INC. | New Position | +892K | +$25.0M |
| OBERWEIS ASSET MANAGEMENT INC/ | New Position | +808K | +$23.5M |
| Nearwater Capital Markets, Ltd | New Position | +615K | +$17.0M |
| FISHMAN JAY A LTD/MI | New Position | +565K | +$16.4M |
| MPM BioImpact LLC | New Position | +531K | +$15.4M |
| BAMCO INC /NY/ | New Position | +505K | +$14.7M |
| Capitolis Liquid Global Markets LLC | New Position | +500K | +$14.0M |
| ZEVENBERGEN CAPITAL INVESTMENTS LLC | New Position | +418K | +$12.1M |
| Point72 Asset Management, L.P. | New Position | +425K | +$12.0M |
| Privium Fund Management B.V. | New Position | +306K | +$8.9M |
| CASTLEARK MANAGEMENT LLC | New Position | +309K | +$8.0M |
| RENAISSANCE TECHNOLOGIES LLC | New Position | +274K | +$7.0M |
ARQT — Institutions Reducing or Closing Positions
| Fund | Action | Shares Sold | Value Sold |
|---|---|---|---|
| Rubric Capital Management LP | Decreased | -2.5M | -$202.4B |
| JANUS HENDERSON GROUP PLC | Decreased | -568K | -$45.1B |
| FRANKLIN RESOURCES INC | Decreased | -411K | -$43.5B |
| Pivotal bioVenture Partners Investment Advisor LLC | Decreased | -754K | -$39.9B |
| Perpetual Ltd | Decreased | -1.1M | -$38.1B |
| Ensign Peak Advisors, Inc | Decreased | -91K | -$37.5B |
| GOLDMAN SACHS GROUP INC | Decreased | -229K | -$34.0B |
| AMERICAN CENTURY COMPANIES INC | Decreased | -195K | -$31.3B |
| Qube Research & Technologies Ltd | Decreased | -153K | -$15.3B |
| Cormorant Asset Management, LP | Decreased | -275K | -$14.6B |
| Aberdeen Group plc | Decreased | -89K | -$12.7B |
| JUPITER ASSET MANAGEMENT LTD | Decreased | -333K | -$12.4B |
| MYDA Advisors LLC | Decreased | -205K | -$8.9B |
| STEMPOINT CAPITAL LP | Decreased | -187K | -$7.8B |
| JANE STREET GROUP, LLC | Decreased | -139K | -$6.8B |
Top Institutional Holders(Q4 2025)
| # | Fund | Shares | Value | % of Portfolio | Type |
|---|---|---|---|---|---|
| 1 | SUVRETTA CAPITAL MANAGEMENT, LLC | 11,964,000 | $347.4M | 7.12% | Share |
| 2 | Frazier Life Sciences Management, L.P. | 9,874,511 | $286.8M | 7.70% | Share |
| 3 | Rubric Capital Management LP | 8,271,577 | $240.2M | 2.87% | Share |
| 4 | VANGUARD GROUP INC | 6,345,829 | $184.3M | 0.00% | Share |
| 5 | JENNISON ASSOCIATES LLC | 5,618,144 | $163.2M | 0.10% | Share |
| 6 | Polar Capital Holdings Plc | 5,556,169 | $161.0M | 0.62% | Share |
| 7 | STATE STREET CORP | 5,488,301 | $159.0M | 0.01% | Share |
| 8 | BlackRock, Inc. | 4,856,125 | $141.0M | 0.00% | Share |
| 9 | GILDER GAGNON HOWE & CO LLC | 4,453,856 | $129.3M | 1.37% | Share |
| 10 | MORGAN STANLEY | 3,579,555 | $103.0M | 0.01% | Share |
| 11 | UBS Group AG | 3,227,619 | $93.7M | 0.02% | Share |
| 12 | BlackRock, Inc. | 3,129,548 | $90.0M | 0.00% | Share |
| 13 | DRIEHAUS CAPITAL MANAGEMENT LLC | 2,562,445 | $74.4M | 0.51% | Share |
| 14 | GEODE CAPITAL MANAGEMENT, LLC | 2,397,851 | $69.0M | 0.00% | Share |
| 15 | D. E. Shaw & Co., Inc. | 2,014,577 | $58.0M | 0.03% | Share |
| 16 | FRANKLIN RESOURCES INC | 1,899,675 | $55.0M | 0.01% | Share |
| 17 | Ensign Peak Advisors, Inc | 1,902,390 | $55.0M | 0.10% | Share |
| 18 | JANUS HENDERSON GROUP PLC | 1,784,961 | $51.0M | 0.02% | Share |
| 19 | AMERICAN CENTURY COMPANIES INC | 1,467,176 | $42.0M | 0.02% | Share |
| 20 | Pivotal bioVenture Partners Investment Advisor LLC | 1,366,624 | $39.7M | 15.34% | Share |
| 21 | JENNISON ASSOCIATES LLC | 1,139,862 | $33.1M | 0.02% | Share |
| 22 | GOLDMAN SACHS GROUP INC | 1,161,689 | $33.0M | 0.00% | Share |
| 23 | PRICE T ROWE ASSOCIATES INC /MD/ | 1,061,761 | $30.0M | 0.00% | Share |
| 24 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1,014,826 | $29.0M | 0.00% | Share |
| 25 | GW&K Investment Management, LLC | 939,456 | $27.3M | 0.24% | Share |
| 26 | VOLORIDGE INVESTMENT MANAGEMENT, LLC | 914,020 | $26.0M | 0.09% | Share |
| 27 | DEUTSCHE BANK AG\ | 922,301 | $26.0M | 0.01% | Share |
| 28 | HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 900,000 | $26.0M | 0.04% | Share |
| 29 | Nuveen, LLC | 870,564 | $25.0M | 0.01% | Share |
| 30 | NORTHERN TRUST CORP | 861,888 | $25.0M | 0.00% | Share |
| 31 | FEDERATED HERMES, INC. | 873,895 | $25.0M | 0.04% | Share |
| 32 | Perpetual Ltd | 823,923 | $23.9M | 0.35% | Share |
| 33 | OBERWEIS ASSET MANAGEMENT INC/ | 808,400 | $23.5M | 0.86% | Share |
| 34 | Candriam S.C.A. | 803,138 | $23.0M | 0.11% | Share |
| 35 | VANGUARD GROUP INC | 763,051 | $22.2M | 0.00% | Share |
| 36 | BANK OF AMERICA CORP /DE/ | 752,572 | $21.0M | 0.00% | Share |
| 37 | BANK OF AMERICA CORP /DE/ | 700,800 | $20.0M | 0.00% | Share |
| 38 | BNP PARIBAS FINANCIAL MARKETS | 699,803 | $20.0M | 0.01% | Share |
| 39 | D. E. Shaw & Co., Inc. | 668,510 | $19.0M | 0.01% | Share |
| 40 | Qube Research & Technologies Ltd | 661,415 | $19.0M | 0.02% | Share |
| 41 | Nearwater Capital Markets, Ltd | 615,000 | $17.0M | 0.29% | Share |
| 42 | Aberdeen Group plc | 584,244 | $17.0M | 0.03% | Share |
| 43 | FISHMAN JAY A LTD/MI | 564,650 | $16.4M | 1.35% | Share |
| 44 | MPM BioImpact LLC | 531,200 | $15.4M | 1.77% | Share |
| 45 | BAMCO INC /NY/ | 504,700 | $14.7M | 0.04% | Share |
| 46 | Cormorant Asset Management, LP | 500,000 | $14.5M | 0.67% | Share |
| 47 | AQR CAPITAL MANAGEMENT LLC | 491,440 | $14.0M | 0.01% | Share |
| 48 | Capitolis Liquid Global Markets LLC | 500,000 | $14.0M | 0.08% | Share |
| 49 | Nuveen, LLC | 477,654 | $13.0M | 0.00% | Share |
| 50 | Squarepoint Ops LLC | 455,876 | $13.0M | 0.01% | Share |
ARQT Institutional Ownership History
| Quarter | Holders | Total Value | Change |
|---|---|---|---|
| Q4 2025 | 279 | $3.6B | +101 |
| Q3 2025 | 178 | $2.0T | -11 |
| Q2 2025 | 189 | $1.4T | -51 |
| Q1 2025 | 240 | $1.9T | +36 |
| Q4 2024 | 204 | $6.8T | +43 |
| Q3 2024 | 161 | $798.3T | +8 |
| Q2 2024 | 153 | $688.9T | +9 |
| Q1 2024 | 144 | $709.3T | — |
Similar Stocks by Institutional Ownership
As of Q4 2025, 50 institutional investors hold ARQT (Arcutis Biotherapeutics, Inc.). The largest holder is SUVRETTA CAPITAL MANAGEMENT, LLC with $347.4M in shares. This quarter, 14 institutions opened new positions and 0 closed their positions.
Frequently Asked Questions
How many hedge funds own ARQT?
As of Q4 2025, 50 institutional investors report holding ARQT (Arcutis Biotherapeutics, Inc.) in their 13F filings.
Who is the largest institutional holder of ARQT?
The largest institutional holder of ARQT is SUVRETTA CAPITAL MANAGEMENT, LLC with $347.4M in shares.
Is institutional ownership of ARQT increasing or decreasing?
This quarter, 14 institutions opened new positions in ARQT and 0 closed their positions.